BIO-key International (NASDAQ:BKYI) Stock Passes Below Two Hundred Day Moving Average – Should You Sell?

BIO-key International Inc. (NASDAQ:BKYI) shares crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $5.12 and traded as low as $3.03. BIO-key International shares last traded at $3.07, with a volume of 23,311 shares trading hands.

Analyst Ratings Changes

Several equities analysts have issued reports on the stock. Weiss Ratings restated a “sell (e+)” rating on shares of BIO-key International in a research note on Friday, July 17th. Zacks Research raised BIO-key International to a “hold” rating in a report on Thursday, August 6th. One investment analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Reduce”.

BIO-key International Trading Down 1.0%

The business’s fifty day moving average price is $4.24 and its 200 day moving average price is $5.12. The firm has a market capitalization of $4.42 million, a price-to-earnings ratio of -0.75 and a beta of 0.44.

BIO-key International (NASDAQ:BKYI) last issued its quarterly earnings results on Thursday, August 13th. The technology company reported ($0.56) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.82) by $0.26. BIO-key International had a negative net margin of 50.01% and a negative return on equity of 67.31%. The firm had revenue of $1.92 million during the quarter, compared to analysts’ expectations of $1.80 million. As a group, sell-side analysts forecast that BIO-key International Inc. will post -1.62 earnings per share for the current fiscal year.

Hedge Funds Weigh In On BIO-key International

An institutional investor recently raised its stake in BIO-key International stock. Geode Capital Management LLC boosted its stake in shares of BIO-key International Inc. (NASDAQ:BKYI) by 49.9% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 48,892 shares of the technology company’s stock after acquiring an additional 16,271 shares during the quarter. Geode Capital Management LLC owned about 0.45% of BIO-key International worth $26,000 as of its most recent filing with the Securities and Exchange Commission. Hedge funds and other institutional investors own 26.51% of the company’s stock.

BIO-key International Company Profile

BIO-key International, Inc is a developer and provider of fingerprint biometric identity and access management solutions, serving enterprise and government customers. The company’s core offerings include a range of fingerprint readers and authentication software designed to verify user identity across physical and digital environments. By leveraging proprietary template-on-card and template-on-device technologies, BIO-key seeks to enhance security and streamline user access without reliance on traditional passwords.

In addition to hardware sensors, BIO-key delivers software platforms that integrate with existing IT infrastructures such as Microsoft Active Directory and major workforce management systems.